{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:48:59Z","timestamp":1789080539778,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11274-021-03000-x","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T08:15:19Z","timestamp":1612944919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine"],"prefix":"10.1007","volume":"37","author":[{"given":"Sanaz","family":"Jafarpour Azami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Mohammad Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2568-9022","authenticated-orcid":false,"given":"Hamed","family":"Mirjalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"3000_CR1","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2147\/IJN.S122178","volume":"12","author":"OS Adeyemi","year":"2017","unstructured":"Adeyemi OS, Murata Y, Sugi T, Kato K (2017) Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential. Int J Nanomedicine 12:1647\u20131661","journal-title":"Int J Nanomedicine"},{"key":"3000_CR2","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1080\/21691401.2018.1489267","volume":"46","author":"OS Adeyemi","year":"2018","unstructured":"Adeyemi OS, Molefe NI, Awakan OJ, Nwonuma CO, Alejolowo OO, Olaolu T, Maimako RF, Suganuma K, Han Y, Kato K (2018) Metal nanoparticles restrict the growth of protozoan parasites. Artif Cells Nanomed Biotechnol 46:S86\u2013s94","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3000_CR3","doi-asserted-by":"crossref","unstructured":"Adeyemi OS, Murata Y, Sugi T, Han Y, Kato K (2019) Nanoparticles show potential to retard bradyzoites in vitro formation of Toxoplasma gondii. Folia Parasitol (Praha) 66","DOI":"10.14411\/fp.2019.001"},{"key":"3000_CR4","doi-asserted-by":"crossref","unstructured":"Alajmi RA, Al-Megrin WA, Metwally D, Al-Subaie H, Altamrah N, Barakat AM, Abdel Moneim AE, Al-Otaibi TT, El-Khadragy M (2019) Anti-Toxoplasma activity of silver nanoparticles green synthesized with Phoenix dactylifera and Ziziphus spina-christi extracts which inhibits inflammation through liver regulation of cytokines in Balb\/c mice. Biosci Rep 39","DOI":"10.1042\/BSR20190379"},{"key":"3000_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/DDDT.S60973","volume":"11","author":"PH Alday","year":"2017","unstructured":"Alday PH, Doggett JS (2017) Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Develop Therap 11:273\u2013293","journal-title":"Drug Des Develop Therap"},{"key":"3000_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri1547","volume":"5","author":"J Aliberti","year":"2005","unstructured":"Aliberti J (2005) Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nat Rev Immunol 5:162\u2013170","journal-title":"Nat Rev Immunol"},{"key":"3000_CR7","first-page":"138","volume":"117","author":"SJ Azami","year":"2018","unstructured":"Azami SJ, Amani A, Keshavarz H, Najafi-Taher R, Mohebali M, Faramarzi MA, Mahmoudi M, Shojaee S (2018a) Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis. Eur J Pharm Sci Off J Eur Fed Pharm Sci 117:138\u2013146","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"key":"3000_CR8","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.2147\/IJN.S181896","volume":"13","author":"SJ Azami","year":"2018","unstructured":"Azami SJ, Teimouri A, Keshavarz H, Amani A, Esmaeili F, Hasanpour H, Elikaee S, Salehiniya H, Shojaee S (2018b) Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice. Int J Nanomedicine 13:7363\u20137374","journal-title":"Int J Nanomedicine"},{"key":"3000_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1128\/AAC.46.5.1163-1173.2002","volume":"46","author":"AL Baggish","year":"2002","unstructured":"Baggish AL, Hill DR (2002) Antiparasitic agent atovaquone. Antimicrob Agents Chemother 46:1163\u20131173","journal-title":"Antimicrob Agents Chemother"},{"key":"3000_CR10","first-page":"1","volume":"20","author":"H Bahadar","year":"2016","unstructured":"Bahadar H, Maqbool F, Niaz K, Abdollahi M (2016) Toxicity of nanoparticles and an overview of current experimental models. Iran Biomed J 20:1\u201311","journal-title":"Iran Biomed J"},{"key":"3000_CR11","doi-asserted-by":"publisher","first-page":"13608","DOI":"10.1021\/jp712087m","volume":"112","author":"C Carlson","year":"2008","unstructured":"Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ (2008) Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 112:13608\u201313619","journal-title":"J Phys Chem B"},{"key":"3000_CR12","doi-asserted-by":"crossref","unstructured":"Cern A, Connolly KL, Jerse AE, Barenholz Y (2018) In vitro susceptibility of Neisseria gonorrhoeae strains to mupirocin, an antibiotic reformulated for parenteral administration in nanoliposomes. Antimicrob Agents Chemother 62","DOI":"10.1128\/AAC.02377-17"},{"key":"3000_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/CMR.12.4.564","volume":"12","author":"MM Cowan","year":"1999","unstructured":"Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12:564\u2013582","journal-title":"Clin Microbiol Rev"},{"key":"3000_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/17425247.2020.1700227","volume":"17","author":"MJ Dar","year":"2020","unstructured":"Dar MJ, McElroy CA, Khan MI, Satoskar AR, Khan GM (2020) Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis. Expert Opin Drug Del 17:97\u2013110","journal-title":"Expert Opin Drug Del"},{"key":"3000_CR15","first-page":"195","volume":"111","author":"A Darade","year":"2018","unstructured":"Darade A, Pathak S, Sharma S, Patravale V (2018) Atovaquone oral bioavailability enhancement using electrospraying technology. Eur J Pharm Sci Off J Eur Fed Pharm Sci 111:195\u2013204","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"key":"3000_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2307\/3283305","volume":"78","author":"ML Dard\u00e9","year":"1992","unstructured":"Dard\u00e9 ML, Bouteille B, Pestre-Alexandre M (1992) Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J Parasitol 78:786\u2013794","journal-title":"J Parasitol"},{"key":"3000_CR17","doi-asserted-by":"publisher","first-page":"7855","DOI":"10.2147\/IJN.S143324","volume":"12","author":"JGB De Marchi","year":"2017","unstructured":"De Marchi JGB, Jornada DS, Silva FK, Freitas AL, Fuentefria AM, Pohlmann AR, Guterres SS (2017) Triclosan resistance reversion by encapsulation in chitosan-coated-nanocapsule containing \u03b1-bisabolol as core: development of wound dressing. Int J Nanomedicine 12:7855\u20137868","journal-title":"Int J Nanomedicine"},{"key":"3000_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0001-706X(03)00194-3","volume":"88","author":"K De\u011ferli","year":"2003","unstructured":"De\u011ferli K, Kilimcio\u011flu AA, Kurt O, Tamay AT, Ozbilgin A (2003) Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey. Acta Trop 88:45\u201350","journal-title":"Acta Trop"},{"key":"3000_CR19","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1645\/GE-2605.1","volume":"96","author":"GW Esch","year":"2010","unstructured":"Esch GW (2010) Toxoplasmosis of animals and humans. J Parasitol 96:940\u2013940","journal-title":"J Parasitol"},{"key":"3000_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12639-017-0973-8","volume":"42","author":"SE Etewa","year":"2018","unstructured":"Etewa SE, El-Maaty DAA, Hamza RS, Metwaly AS, Sarhan MH, Abdel-Rahman SA, Fathy GM, El-Shafey MA (2018) Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice. J Parasit Dis 42:102\u2013113","journal-title":"J Parasit Dis"},{"key":"3000_CR21","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3389\/fpsyt.2019.01012","volume":"10","author":"J Flegr","year":"2019","unstructured":"Flegr J, Hor\u00e1\u010dek J (2019) Negative effects of latent toxoplasmosis on mental health. Front Psych 10:1012","journal-title":"Front Psych"},{"key":"3000_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090203","volume":"9","author":"J Flegr","year":"2014","unstructured":"Flegr J, Prandota J, Sovickova M, Israili ZH (2014) Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One 9:e90203","journal-title":"PLoS One"},{"key":"3000_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.exppara.2014.05.005","volume":"143","author":"MR Gaafar","year":"2014","unstructured":"Gaafar MR, Mady RF, Diab RG, Shalaby TI (2014) Chitosan and silver nanoparticles: promising anti-Toxoplasma agents. Exp Parasitol 143:30\u201338","journal-title":"Exp Parasitol"},{"key":"3000_CR24","first-page":"2399","volume":"9","author":"L Ge","year":"2014","unstructured":"Ge L, Li Q, Wang M, Ouyang J, Li X, Xing MM (2014) Nanosilver particles in medical applications: synthesis, performance, and toxicity. Int J Nanomedicine 9:2399\u20132407","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"3000_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1590\/S0104-14282009000300013","volume":"19","author":"R Goy","year":"2009","unstructured":"Goy R, Britto DD, Assis O (2009) A review of the antimicrobial activity of chitosan. Polimeros: Ciencia et Tecnologia 19(3):241\u2013247","journal-title":"Polimeros: Ciencia et Tecnologia"},{"key":"3000_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2019.107717","volume":"204","author":"NA Hagras","year":"2019","unstructured":"Hagras NA, Allam AF, Farag HF, Osman MM, Shalaby TI, Fawzy Hussein Mogahed NM, Tolba MM, Shehab AY (2019) Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles. Exp Parasitol 204:107717","journal-title":"Exp Parasitol"},{"key":"3000_CR27","first-page":"634","volume":"8","author":"D Hill","year":"2002","unstructured":"Hill D, Dubey JP (2002) Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 8:634\u2013640","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"3000_CR28","doi-asserted-by":"crossref","unstructured":"Hill DE, Dubey JP (2016) Toxoplasma gondii as a parasite in food: analysis and control. Microbiol Spectr 4","DOI":"10.1128\/microbiolspec.PFS-0011-2015"},{"key":"3000_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.toxlet.2008.04.015","volume":"179","author":"YH Hsin","year":"2008","unstructured":"Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ (2008) The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 179:130\u2013139","journal-title":"Toxicol Lett"},{"key":"3000_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13205-014-0214-0","volume":"5","author":"M Jaiswal","year":"2015","unstructured":"Jaiswal M, Dudhe R, Sharma PK (2015) Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech 5:123\u2013127","journal-title":"3 Biotech"},{"key":"3000_CR31","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1021\/es100854g","volume":"44","author":"X Jin","year":"2010","unstructured":"Jin X, Li M, Wang J, Marambio-Jones C, Peng F, Huang X, Damoiseaux R, Hoek EM (2010) High-throughput screening of silver nanoparticle stability and bacterial inactivation in aquatic media: influence of specific ions. Environ Sci Technol 44:7321\u20137328","journal-title":"Environ Sci Technol"},{"key":"3000_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4269\/ajtmh.2007.77.405","volume":"77","author":"JL Jones","year":"2007","unstructured":"Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M (2007) Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg 77:405\u2013410","journal-title":"Am J Trop Med Hyg"},{"key":"3000_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1099\/jmm.0.001111","volume":"69","author":"A Keyhani","year":"2020","unstructured":"Keyhani A, Ziaali N, Shakibaie M, Kareshk AT, Shojaee S, Asadi-Shekaari M, Sepahvand M, Mahmoudvand H (2020) Biogenic selenium nanoparticles target chronic toxoplasmosis with minimal cytotoxicity in a mouse model. J Med Microbiol 69:104\u2013110","journal-title":"J Med Microbiol"},{"key":"3000_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fcimb.2020.00033","volume":"10","author":"M Khosravi","year":"2020","unstructured":"Khosravi M, Mohammad Rahimi H, Doroud D, Mirsamadi ES, Mirjalali H, Zali MR (2020) In vitro evaluation of mannosylated paromomycin-loaded solid lipid nanoparticles on acute toxoplasmosis. Front Cell Infect Microbiol 10:33","journal-title":"Front Cell Infect Microbiol"},{"key":"3000_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1248\/bpb.25.131","volume":"25","author":"T Koide","year":"2002","unstructured":"Koide T, Nose M, Ogihara Y, Yabu Y, Ohta N (2002) Leishmanicidal effect of curcumin in vitro. Biol Pharm Bull 25:131\u2013133","journal-title":"Biol Pharm Bull"},{"key":"3000_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF01875349","volume":"102","author":"BC Kone","year":"1988","unstructured":"Kone BC, Kaleta M, Gullans SR (1988) Silver ion (Ag+)-induced increases in cell membrane K+ and Na+ permeability in the renal proximal tubule: reversal by thiol reagents. J Membr Biol 102:11\u201319","journal-title":"J Membr Biol"},{"key":"3000_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1515\/ejnm-2014-0032","volume":"7","author":"M Korani","year":"2015","unstructured":"Korani M, Ghazizadeh E, Korani S, Hami Z, Mohammadi-Bardbori A (2015) Effects of silver nanoparticles on human health. Eur J Nanomedicine 7:51\u201362","journal-title":"Eur J Nanomedicine"},{"key":"3000_CR38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1586\/erv.09.27","volume":"8","author":"J Kur","year":"2009","unstructured":"Kur J, Holec-Gasior L, Hiszczy\u0144ska-Sawicka E (2009) Current status of toxoplasmosis vaccine development. Expert Rev Vaccines 8:791\u2013808","journal-title":"Expert Rev Vaccines"},{"key":"3000_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2020.107853","volume":"211","author":"LF Machado","year":"2020","unstructured":"Machado LF, Sanfelice RA, Bosqui LR, Assolini JP, Scandorieiro S, Navarro IT, Depieri Cataneo AH, Wowk PF, Nakazato G, Bordignon J, Pavanelli WR, Conchon-Costa I, Costa IN (2020) Biogenic silver nanoparticles reduce adherence, infection, and proliferation of Toxoplasma gondii RH strain in HeLa cells without inflammatory mediators induction. Exp Parasitol 211:107853","journal-title":"Exp Parasitol"},{"key":"3000_CR40","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1128\/9781555817381.ch138","volume-title":"Manual of clinical microbiology","author":"JB Mcauley","year":"2015","unstructured":"Mcauley JB, Jones JL, Singh K (2015) Toxoplasma. In: Manual of clinical microbiology, 11th edn. American Society of Microbiology, Washington, DC, pp 2373\u20132386","edition":"11"},{"key":"3000_CR41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/01.inf.0000202070.59190.9a","volume":"25","author":"R McLeod","year":"2006","unstructured":"McLeod R, Khan AR, Noble GA, Latkany P, Jalbrzikowski J, Boyer K (2006) Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis. Pediatr Infect Dis J 25:270\u2013272","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"3000_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fcimb.2019.00185","volume":"6","author":"SJ Melchor","year":"2019","unstructured":"Melchor SJ, Ewald SE (2019) Disease tolerance in Toxoplasma infection. Front Cell Infect Microbiol 6(9):185","journal-title":"Front Cell Infect Microbiol"},{"key":"3000_CR43","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1002\/fsn3.1648","volume":"8","author":"H Mohammad Rahimi","year":"2020","unstructured":"Mohammad Rahimi H, Khosravi M, Hesari Z, Sharifdini M, Mirjalali H, Zali MR (2020) Anti-Toxoplasma activity and chemical compositions of aquatic extract of Mentha pulegium L. and Rubus idaeus L.: an in vitro study. Food Sci Nutr 8:3656\u20133664","journal-title":"Food Sci Nutr"},{"key":"3000_CR44","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965\u20131976","journal-title":"Lancet"},{"key":"3000_CR45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/clinids\/23.2.277","volume":"23","author":"JG Montoya","year":"1996","unstructured":"Montoya JG, Remington JS (1996) Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 23:277\u2013282","journal-title":"Clin Infect Dis"},{"key":"3000_CR46","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/590149","volume":"47","author":"JG Montoya","year":"2008","unstructured":"Montoya JG, Remington JS (2008) Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 47:554\u2013566","journal-title":"Clin Infect Dis"},{"key":"3000_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.parepi.2020.e00156","volume":"10","author":"A Nafari","year":"2020","unstructured":"Nafari A, Cheraghipour K, Sepahvand M, Shahrokhi G, Gabal E, Mahmoudvand H (2020) Nanoparticles: new agents toward treatment of leishmaniasis. Parasite Epidemiol Control 10:e00156","journal-title":"Parasite Epidemiol Control"},{"key":"3000_CR48","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1021\/nl072377+","volume":"7","author":"D Pissuwan","year":"2007","unstructured":"Pissuwan D, Valenzuela SM, Miller CM, Cortie MB (2007) A golden bullet? Selective targeting of Toxoplasma gondii tachyzoites using antibody-functionalized gold nanorods. Nano Lett 7:3808\u20133812","journal-title":"Nano Lett"},{"key":"3000_CR49","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2147\/IJN.S190692","volume":"14","author":"K Rahman","year":"2019","unstructured":"Rahman K, Khan SU, Fahad S, Chang MX, Abbas A, Khan WU, Rahman L, Haq ZU, Nabi G, Khan D (2019) Nano-biotechnology: a new approach to treat and prevent malaria. Int J Nanomedicine 14:1401\u20131410","journal-title":"Int J Nanomedicine"},{"key":"3000_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/10934529.2015.975042","volume":"50","author":"MA Randhawa","year":"2015","unstructured":"Randhawa MA, Gondal MA, Al-Zahrani AH, Rashid SG, Ali A (2015) Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm. J Environ Sci Health A Tox Hazard Subst Environ Eng 50:119\u2013124","journal-title":"J Environ Sci Health A Tox Hazard Subst Environ Eng"},{"key":"3000_CR51","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1128\/AAC.45.6.1771-1779.2001","volume":"45","author":"N Sch\u00f6ler","year":"2001","unstructured":"Sch\u00f6ler N, Krause K, Kayser O, M\u00fcller RH, Borner K, Hahn H, Liesenfeld O (2001) Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother 45:1771\u20131779","journal-title":"Antimicrob Agents Chemother"},{"key":"3000_CR52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2174\/1574891X10666150410120321","volume":"9","author":"JC Sepulveda-Arias","year":"2014","unstructured":"Sepulveda-Arias JC, Veloza LA, Mantilla-Muriel LE (2014) Anti-Toxoplasma activity of natural products: a review. Recent Pat Antiinfect Drug Discov 9:186\u2013194","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"3000_CR53","first-page":"362","volume":"14","author":"S Shojaee","year":"2019","unstructured":"Shojaee S, Firouzeh N, Keshavarz H, Jafar-Pour Azami S, Salimi M, Mohebali M (2019) Nanosilver colloid inhibits Toxoplasma gondii tachyzoites and bradyzoites in vitro. Iran J Parasitol 14:362\u2013367","journal-title":"Iran J Parasitol"},{"key":"3000_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/10611861003733995","volume":"19","author":"HM Shubar","year":"2011","unstructured":"Shubar HM, Lachenmaier S, Heimesaat MM, Lohman U, Mauludin R, Mueller RH, Fitzner R, Borner K, Liesenfeld O (2011) SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers. J Drug Target 19:114\u2013124","journal-title":"J Drug Target"},{"key":"3000_CR55","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/aur.1722","volume":"10","author":"MN Spann","year":"2017","unstructured":"Spann MN, Sourander A, Surcel HM, Hinkka-Yli-Salom\u00e4ki S, Brown AS (2017) Prenatal toxoplasmosis antibody and childhood autism. Autism Res Off J Int Soc Autism Res 10:769\u2013777","journal-title":"Autism Res Off J Int Soc Autism Res"},{"key":"3000_CR56","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1080\/10717544.2019.1692968","volume":"26","author":"Y Sun","year":"2019","unstructured":"Sun Y, Chen D, Pan Y, Qu W, Hao H, Wang X, Liu Z, Xie S (2019) Nanoparticles for antiparasitic drug delivery. Drug Deliv 26:1206\u20131221","journal-title":"Drug Deliv"},{"key":"3000_CR57","first-page":"102","volume":"8","author":"V Surender","year":"2016","unstructured":"Surender V, Deepika M (2016) Solid lipid nanoparticles: a comprehensive review. J Chem Pharm Res 8:102\u2013114","journal-title":"J Chem Pharm Res"},{"key":"3000_CR58","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2147\/IJN.S158736","volume":"13","author":"A Teimouri","year":"2018","unstructured":"Teimouri A, Azami SJ, Keshavarz H, Esmaeili F, Alimi R, Mavi SA, Shojaee S (2018) Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain. Int J Nanomedicine 13:1341\u20131351","journal-title":"Int J Nanomedicine"},{"key":"3000_CR59","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2471\/BLT.12.111732","volume":"91","author":"PR Torgerson","year":"2013","unstructured":"Torgerson PR, Mastroiacovo P (2013) The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 91:501\u2013508","journal-title":"Bull World Health Organ"},{"key":"3000_CR60","doi-asserted-by":"crossref","unstructured":"Vergara-Duque D, Cifuentes-Yepes L, Hincapie-Ria\u00f1o T, Clavijo-Acosta F, Juez-Castillo G, Valencia-Vidal B (2020) Effect of silver nanoparticles on the morphology of Toxoplasma gondii and Salmonella braenderup. J Nanotech 2020","DOI":"10.1155\/2020\/9483428"},{"key":"3000_CR61","first-page":"765","volume":"6","author":"JJ Wang","year":"2011","unstructured":"Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou GL, Zhan XR, Wang SL (2011) Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 6:765\u2013774","journal-title":"Int J Nanomedicine"},{"key":"3000_CR62","doi-asserted-by":"crossref","unstructured":"Yadollahi R, Vasilev K, Simovic S (2015) Nanosuspension technologies for delivery of poorly soluble drugs. J Nanomaterial 2015","DOI":"10.1155\/2015\/216375"},{"key":"3000_CR63","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1208\/s12248-015-9811-z","volume":"17","author":"MM Yallapu","year":"2015","unstructured":"Yallapu MM, Nagesh PK, Jaggi M, Chauhan SC (2015) Therapeutic applications of curcumin nanoformulations. AAPS J 17:1341\u20131356","journal-title":"AAPS J"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-021-03000-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-021-03000-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-021-03000-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T05:21:03Z","timestamp":1674969663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-021-03000-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3000"],"URL":"https:\/\/doi.org\/10.1007\/s11274-021-03000-x","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"7 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards (IR.SBMU.RIGLD.REC.1398.034) released by the Ethical Review Committee of the Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"48"}}